the efficacy of recombinant leukocyte a interferon ( rifn-alpha a [ roferon-a , hoffman-la roche , nutley , nj ] ) treatment of kaposi 's sarcoma in patients with acquired immunodeficiency syndrome was evaluated in sequential trials using high doses ( 36 x 10 ( 6 ) units ) and low doses ( 3 x 10 ( 6 ) units ) of interferon .
C0001175
acquired immunodeficiency syndrome
C0021747
interferon